LLL-3 inhibits STAT3 activity, suppresses glioblastoma cell growth and prolongs survival in a mouse glioblastoma model
Open Access
- 6 January 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 100 (1), 106-112
- https://doi.org/10.1038/sj.bjc.6604793
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activityProceedings of the National Academy of Sciences of the United States of America, 2007
- Antiproliferative Mechanisms of a Transcription Factor Decoy Targeting Signal Transducer and Activator of Transcription (STAT) 3: The Role of STAT1Molecular Pharmacology, 2007
- Stat3 activation in human endometrial and cervical cancersBritish Journal of Cancer, 2007
- A semiempirical free energy force field with charge‐based desolvationJournal of Computational Chemistry, 2007
- Essential Role of STAT3 in Postnatal Survival and Growth Revealed by Mice Lacking STAT3 Serine 727 PhosphorylationMolecular and Cellular Biology, 2004
- Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphomaBlood, 2003
- The role of STATs in transcriptional control and their impact on cellular functionOncogene, 2000
- Oxidative Stress Triggers STAT3 Tyrosine Phosphorylation and Nuclear Translocation in Human LymphocytesPublished by Elsevier BV ,1999
- Dominant Negative Stat3 Mutant Inhibits Interleukin-6-induced Jak-STAT Signal TransductionPublished by Elsevier BV ,1996
- Stat3: a STAT Family Member Activated by Tyrosine Phosphorylation in Response to Epidermal Growth Factor and Interleukin-6Science, 1994